The First Clinical Evidence that the Drug Mavoglurant Improves Responsiveness in Fragile X Syndrome (FXS)

Results of a study reported in PLOS ONE that was conducted by a team of scientists indicate that the experimental drug mavoglurant improves responsiveness and eye gaze for patients with…

Continue Reading The First Clinical Evidence that the Drug Mavoglurant Improves Responsiveness in Fragile X Syndrome (FXS)

First Patient to Receive Gene Therapy in a Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease

Actus Therapeutics, a privately held portfolio company of AskBio, has recently announced through PRWeb, the initiation of patient dosing in a clinical trial testing its investigational gene therapy ACTUS-101. About Pompe…

Continue Reading First Patient to Receive Gene Therapy in a Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease
First Patient Dosed in Clinical Trial of Cystic Fibrosis with Severe Exocrine Pancreatic Insufficiency
derneuemann / Pixabay

First Patient Dosed in Clinical Trial of Cystic Fibrosis with Severe Exocrine Pancreatic Insufficiency

According to a story from BioSpace, the biopharmaceutical company AzuRx BioPharma Inc. recently announced that the first patient has been treated in the company's phase 2 clinical trial. This trial…

Continue Reading First Patient Dosed in Clinical Trial of Cystic Fibrosis with Severe Exocrine Pancreatic Insufficiency
ICYMI: This Mother Showed Doctors Videos of Her Son Chatting and Running Around Before he Regressed. They Finally Found an Answer 12 Years Later
kittyflake / Pixabay

ICYMI: This Mother Showed Doctors Videos of Her Son Chatting and Running Around Before he Regressed. They Finally Found an Answer 12 Years Later

As originally reported on NPR, Alex Yiu’s mom has a montage of her son's early years. As one watches the videos, you see something: him losing control. He begins to…

Continue Reading ICYMI: This Mother Showed Doctors Videos of Her Son Chatting and Running Around Before he Regressed. They Finally Found an Answer 12 Years Later
Man with Cystic Fibrosis Goes From 24/7 Oxygen Tank to an Avid Biker 24 Years After his Lung Transplant
source: pixabay.com

Man with Cystic Fibrosis Goes From 24/7 Oxygen Tank to an Avid Biker 24 Years After his Lung Transplant

  When Frankie Avila first got his lung transplant, he was told that, like most organs that are transplanted, his lungs only have a certain amount of time before they…

Continue Reading Man with Cystic Fibrosis Goes From 24/7 Oxygen Tank to an Avid Biker 24 Years After his Lung Transplant
Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug
sbtlneet / Pixabay

Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug

According to a story from BioSpace, Oncotelic, Inc., recently announced the publication of a study in the Journal of Clinical Research in Pediatrics. This study appears to back up the therapeutic…

Continue Reading Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug
11 Year Old Aims to Spread Awareness about Primary Pulmonary Hypertension, a Rare Disease That has Ravaged Her Family
Free-Photos / Pixabay

11 Year Old Aims to Spread Awareness about Primary Pulmonary Hypertension, a Rare Disease That has Ravaged Her Family

According to a story from the Borehamwood & Elstree Times, the family of 11 year old girl Sivan Hermon is plagued by a rare disease: primary pulmonary hypertension. As the…

Continue Reading 11 Year Old Aims to Spread Awareness about Primary Pulmonary Hypertension, a Rare Disease That has Ravaged Her Family

A Teenager was Killed by a Disease so Rare it Didn’t Have a Name, But His Story Could Change the Lives of Others Like Him

According to a story from NBC News, Mitchell Herndon, a 19 year old from Missouri, recently passed away due to the progression of a rare genetic disease that is so…

Continue Reading A Teenager was Killed by a Disease so Rare it Didn’t Have a Name, But His Story Could Change the Lives of Others Like Him
A Man with CIDP Slid 400 Feet Down the New River Gorge’s High-Line in a Wheelchair.
Free-Photos / Pixabay

A Man with CIDP Slid 400 Feet Down the New River Gorge’s High-Line in a Wheelchair.

As originally reported in WWVA, West Virginian Sib Weatherford spent one afternoon this fall doing what nobody though possible: he slid 400 feet down the New River Gorge's high-line in…

Continue Reading A Man with CIDP Slid 400 Feet Down the New River Gorge’s High-Line in a Wheelchair.
Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia
Anqa / Pixabay

Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia

According to a story from Healio, the results from a recent phase 2A clinical trial have demonstrated the effectiveness of an experimental drug in treating congenital adrenal hyperplasia (CAH). The…

Continue Reading Experimental Non-Steroid Treatment Displays Potential for Congenital Adrenal Hyperplasia
A Girl Diagnosed with Batten Disease got Treated with a Drug Developed Specifically for Her
DarkoStojanovic / Pixabay

A Girl Diagnosed with Batten Disease got Treated with a Drug Developed Specifically for Her

According to a story from Technology Review, the story of Mila Makovec shows the potential impact that personalized medicine could have on patients while also revealing some of its limitations.…

Continue Reading A Girl Diagnosed with Batten Disease got Treated with a Drug Developed Specifically for Her
Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment
source: pixabay.com

Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment

BrainStorm Cell Therapeutics has just announced that they have completed enrollment in their Phase 3 clinical trial for amyotrophic lateral sclerosis (ALS). Enrollment was initiated way back in October of…

Continue Reading Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment
Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes
source: pixabay.com

Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes

According to a story from PR Newswire, the nonprofit groups Duchenne UK and Parent Project Muscular Dystrophy (PPMD) have jointly awarded grant funding to the tune of $200,000 to Dr.…

Continue Reading Two Nonprofits Award $200,000 Grant for Development of Duchenne Muscular Dystrophy Patient Reported Outcomes